Carvedilol Ameliorates Experimental Atherosclerosis by Regulating Cholesterol Efflux and Exosome Functions

Carvedilol (Cav), a nonselective β-blocker with α1 adrenoceptor blocking effect, has been used as a standard therapy for coronary artery disease. This study investigated the effects of Cav on exosome expression and function, ATP-binding cassette transporter A1 (ABCA1) expression, and cholesterol eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Sy-Jou, Tsui, Pi-Fen, Chuang, Yi-Ping, Chiang, Dapi Meng-Lin, Chen, Liv Weichien, Liu, Shu-Ting, Lin, Feng-Yen, Huang, Shih-Ming, Lin, Shih-Hua, Wu, Wan-Lin, Tsai, Min-Chien, Lin, Chin-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834197/
https://www.ncbi.nlm.nih.gov/pubmed/31635197
http://dx.doi.org/10.3390/ijms20205202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834197/
https://www.ncbi.nlm.nih.gov/pubmed/31635197
http://dx.doi.org/10.3390/ijms20205202

Ejemplares similares